Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.

Michela GiustozziGiancarlo AgnelliJorge Del Toro-CerveraFrederikus Albertus KlokRachel P RosovskyAnne-Céline MartinJoerg HeroldInna TzoranSebastian SzmitLaurent BertolettiCecilia BecattiniMenno V Huisman

Published in: Thrombosis and haemostasis (2020)

In patients with cancer-associated VTE, oral factor Xa inhibitors reduced the risk of recurrent VTE without a significantly higher likelihood of major bleeding at 6 months compared with LMWH.

Keyphrases

venous thromboembolism
direct oral anticoagulants
liver failure
papillary thyroid
atrial fibrillation
respiratory failure
squamous cell
young adults
intensive care unit
hepatitis b virus
childhood cancer